arrow
A

Alba Pérez-Cordón

instituto de salud carlos iii
H指数:29
被引数:4,813

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A single-center open-label, randomized, parallel-group controlled clinical trial on the long-term effect of the treatment with EGb 761 in blood markers of inflammation and neurodegeneration in patients with mild cognitive impairment: ACE-2020-EGb 761

单中心开放标签、随机、平行组对照临床试验,研究EGb 761治疗对轻度认知障碍患者炎症和神经退行性变血液标志物的长期效果:ACE-2020-EGb 761

2026-09-290
PRE
Exploring sex differences in Alzheimer's disease: a comprehensive analysis of a large patient cohort from a memory unit

探索阿尔茨海默病的性别差异: 来自记忆单元的大型患者队列的综合分析

2025-01-220
OAAI
Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort
2024-11-160
OAAI
Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic

血浆pTau181在记忆诊所大型真实队列中预测阿尔茨海默病病理的临床价值

2024-10-010
OAAI
An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

SIRPβ1内的插入显示出对阿尔茨海默氏病认知下降的双重作用,改变了小胶质细胞的反应

2024-03-191
PRE
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort
2024-02-203
OAAI
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
2023-04-0312
OAAI
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohort
2023-02-235
OAAI
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (vol 12, 3417, 2021)

阿尔茨海默病的常见变异和多基因风险评分的风险分层 (第12卷,3417,2021)

2023-02-090
OAAI
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
2023-01-106
OAAI
Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort
2022-10-087
OAAI
New insights into the genetic etiology of Alzheimer's disease and related dementias

对阿尔茨海默氏病和相关痴呆症的遗传病因的新见解

2022-04-04919
OAAI
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
2022-03-1810
OAAI
Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
2021-12-0811
OA
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
2021-09-289
OAAI
Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort
2021-08-177
OAAI
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

阿尔茨海默病的常见变异和多基因风险评分的风险分层

2021-06-07160
OAAI
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
2021-03-1945
OAAI
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic (vol 10, 20058, 2020)
2021-02-222
OAAI